Fosun International’s Amneal Pharmaceuticals AMRX Stock Holding History

Fosun International’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,720,855	Closed	-$14.3M	–	49
2024 Q3	$14.3M	Sell	1,720,855 -2,934,548	-63%	-$22.9M	4.71%	4
2024 Q2	$29.6M	Sell	4,655,403 -7,658,845	-62%	-$48.6M	9.98%	3
2024 Q1	$74.6M	Sell	12,314,248 -9,207,053	-43%	-$51.9M	23.25%	2
2023 Q4	$131M	Hold	21,521,301	–	–	26.62%	2
2023 Q3	$90.8M	Hold	21,521,301	–	–	14.58%	2
2023 Q2	$66.7M	Hold	21,521,301	–	–	9.35%	2
2023 Q1	$29.9M	Hold	21,521,301	–	–	2.81%	4
2022 Q4	$42.8M	Hold	21,521,301	–	–	3.52%	4
2022 Q3	$43.5M	Hold	21,521,301	–	–	4.65%	5
2022 Q2	$68.4M	Hold	21,521,301	–	–	9.48%	3
2022 Q1	$89.7M	Hold	21,521,301	–	–	7.75%	2
2021 Q4	$103M	Hold	21,521,301	–	–	5.89%	3
2021 Q3	$115M	Hold	21,521,301	–	–	5.88%	3
2021 Q2	$110M	Hold	21,521,301	–	–	6.54%	4
2021 Q1	$145M	Hold	21,521,301	–	–	11.4%	2
2020 Q4	$98.4K	Hold	21,521,301	–	–	6.42%	2
2020 Q3	$83.5M	Hold	21,521,301	–	–	7.34%	2
2020 Q2	$102M	Hold	21,521,301	–	–	9.84%	1
2020 Q1	$74.9M	Hold	21,521,301	–	–	7.28%	3
2019 Q4	$104M	Hold	21,521,301	–	–	8.63%	1
2019 Q3	$62.4M	Buy	21,521,301 +1,969,300	+10%	+$6.87M	6.92%	3
2019 Q2	$140M	Hold	19,552,001	–	–	9.25%	2
2019 Q1	$277M	Hold	19,552,001	–	–	17.6%	1
2018 Q4	$265M	Hold	19,552,001	–	–	15.8%	1
2018 Q3	$434M	Sell	19,552,001 -741,350	-4%	-$15.6M	20.8%	1
2018 Q2	$333M	Buy	+20,293,351	New	+$356M	17%	1

Other funds holding AMRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Fosun International's AMRX Position: Q4 2024 in Review

Fosun International sold out of Amneal Pharmaceuticals (AMRX) in Q4 2024, closing a stake of 1,720,855 shares — an estimated $14.3M sold.

Fosun International first reported a position in AMRX in Q2 2018 and held it in 26 quarters. The position peaked at $434M in Q3 2018. 199 funds tracked by Wall St. Rank hold AMRX as of Q4 2024.

Fosun International reported no remaining Amneal Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Fosun International sold 1,720,855 Amneal Pharmaceuticals shares in Q4 2024, an estimated $14.3M.
Fosun International first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 26 quarters.
Fosun International's Amneal Pharmaceuticals position peaked at $434M in Q3 2018.
199 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2024.

Based on Fosun International's 13F filing for Q4 2024, filed 14 Feb 2025.